A star-shaped molecule along with a modified platinum drug have demonstrated success at combatting tumours with few toxic effects in mice.
List view / Grid view
University of Texas MD Anderson Cancer Center
Filter the results
A protein that causes pancreatic ductal adenocarcinoma has been identified as a therapeutic target by researchers.
Combination therapy with a CHK1 or PARP inhibitor, with an immune checkpoint inhibitor caused the regression of small cell lung cancer in all mice treated...